2021 was Shockwave’s best year yet! Although it brought challenges, with it came immense opportunities which allowed us to grow and exceed expectations. As we push on into 2022, we are excited for what the year will bring but most importantly, for the opportunities to continue to help improve patient outcomes across the globe. But before we get started, let’s review the highlights of last quarter. We released four data releases, including our 1-year results of our Coronary IVL pivotal study at TCT this year, making it a monumental event. We had some exciting peer-reviewed publications come out, enrolled the first patient in the Disrupt BTK II Study, and much more. Read the latest PulsePoint for all the updates!
Read More
Topics:
Coronary IVL,
Peripheral IVL,
IVL Technology,
PulsePoint Newsletter
Alternative access strategies in TAVI are prone to higher complication rates when compared to transfemoral access. This leads to the question; should physicians tackle difficult transfemoral over alternative access?
Read More
Topics:
Peripheral IVL,
Peripheral Conferences,
Peripheral Clinical Data
Dr. Margaret McEntegart, Consultant Interventional Cardiologist at West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital and Honorary Associate Clinical Professor, University of Glasgow, Glasgow, United Kingdom speaks about her experience with coronary IVL including practice-changing findings from her research comparing costs and resource utilization of rotational atherectomy vs. coronary Intravascular Lithotripsy.
Read More
Topics:
Coronary IVL,
Shockwave C2,
Calcium Corner
For the first time, Shockwave Medical participated in ASIA-PCR, which was entirely virtual because of the ongoing COVID-19 pandemic. Watch our joint symposium with Abiomed entitled: “THE CHALLENGES OF COMPLEX PCI TREATMENT: Mechanical support in CHIP patients and IVL for calcified coronary disease”.
Read More
Topics:
Coronary IVL,
IVL Technology,
Shockwave C2
Great news! The Centers for Medicare and Medicaid Services (CMS) has increased payment for peripheral IVL procedures. The increases apply to procedures performed in anatomical locations above the knee in a hospital outpatient setting. The changes go into effect on January 1, 2022.
Read More
Topics:
Peripheral IVL,
Peripheral Clinical Data,
Reimbursement
In the latest ChalkTalk podcast, we’re going to listen in on a sponsored discussion that took place with TCTMD during TCT21 about new insights on the latest Coronary IVL data that was presented during the meeting with Drs. Ajay Kirtane, Alexandra Lansky, Matthew Price, and Ziad Ali. Hope you enjoy the conversation and for more information on the data, please visit LetsGetCracking.com.
Read More
Topics:
Coronary IVL,
IVL Technology,
SWAV News,
ChalkTalk Podcast,
Treating Different Ca++ Morphologies,
Female vs. Male Outcomes
Transfemoral access represents the gold standard for TAVI, with TF access showing a significant reduction in complications and mortality in comparison to alternative access strategies, which add additional complexity and risk to the procedure. Despite the wide acceptance that the transfemoral route provides the safest access for patients, the approach can be hindered by calcified iliac arteries inhibiting delivery of large bore devices by restricting the luminal diameter and reducing vessel compliance. If calcium is not treated adequately prior to TAVI delivery, this can lead to complications such as flow limiting dissection, vessel rupture and unsuccessful delivery of the implant.
Read More
Topics:
Peripheral IVL,
Peripheral Clinical Data
In the recent Cardiovascular Revascularization Medicine article, “First United States experience with RotaShock: A case series,” Drs. Gautam Kumar and Rajesh Sachdeva of Emory and Atlanta VA Medical Center recount three successful cases using the RotaShock technique, a combination of rotational atherectomy with IVL for severely calcified vessels. Following its publication, we engaged them in a highly educational Q&A discussion about how the two technologies are very complementary to each other, and the new strategy can be used either electively or as a rescue. We hope you enjoy their additional perspective.
Read More
Topics:
Coronary IVL,
Shockwave C2
Dr. Srinivasa Potluri, Chair of the Department of Cardiology and Director of the Cardiac Catheterization Laboratory at Baylor Scott and White, The Heart Hospital in Plano, speaks about his valuable experience with coronary IVL. Dr. Potluri also shares a clinical case with severe ostial RCA and the value of coronary IVL in vessel preparation strategy in the presence of a heavy coronary calcium burden.
Read More
Topics:
Coronary IVL,
Shockwave C2,
Calcium Corner
Winter is coming… and fast but before we enter the final home stretch of the year, let’s recount the milestones of the recent quarter in the latest edition of the PulsePoint Newsletter. Shockwave hit the ground running this quarter by bringing on various IVL experts from across the globe to discuss all things calcium on the ChalkTalk Podcast Series. Shockwave also made headlines in CathLab Digest with several physician-authored perspectives about the role of the technology in clinical practice. And it was great to finally get back to live, in-person conferences like VIVA ’21, where the results from the first 752 patients in the Disrupt PAD III Observational Study were presented. Catch up on what you may have missed and don’t forget watch the CalciumMasterclass.com series finale!
Read More
Topics:
Coronary IVL,
Peripheral IVL,
IVL Technology,
PulsePoint Newsletter